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NanocompositeNovel porous bilayered scaffolds, fully integrating a silk ﬁbroin (SF) layer and a silk-nano calcium phos-
phate (silk-nanoCaP) layer for osteochondral defect (OCD) regeneration, were developed. Homogeneous
porosity distribution was achieved in the scaffolds, with calcium phosphate phase only retained in the
silk-nanoCaP layer. The scaffold presented compressive moduli of 0.4 MPa in the wet state. Rabbit bone
marrow mesenchymal stromal cells (RBMSCs) were cultured on the scaffolds, and good adhesion and
proliferation were observed. The silk-nanoCaP layer showed a higher alkaline phosphatase level than
the silk layer in osteogenic conditions. Subcutaneous implantation in rabbits demonstrated weak
inﬂammation. In a rabbit knee critical size OCD model, the scaffolds ﬁrmly integrated into the host tissue.
Histological and immunohistochemical analysis showed that collagen II positive cartilage and glycosami-
noglycan regeneration presented in the silk layer, and de novo bone ingrowths and vessel formation were
observed in the silk-nanoCaP layer. These bilayered scaffolds can therefore be promising candidates for
OCD regeneration.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Osteochondral defects (OCDs) are a common problem in joints
[1,2], and include defects both in the articular cartilage and the
underlying subchondral bone. Cartilage defects are normally irre-
versible, and would likely induce OCDs. Diseases arising from the
subchondral bone, such as osteochondritis dissecans and osteone-
crosis, can also cause OCDs [3]. Osteochondral fracture constitutes
an important cause of OCDs. Besides the knee, OCDs can also be
found in the ankle, speciﬁcally in the talus [4,5]. OCDs will induce
persistent symptoms of pain and limited motion of the joint. Everyyear, the healthcare cost for OCDs is about $95 billion in the United
States alone [6].
Several techniques are currently used clinically to treat OCDs,
including arthroscopic debridement, microfracture, osteochondral
(OC) autograft transplantation and autologous chondrocyte
implantation [7]. These approaches are not ideal, since they are
palliative or induce donor site morbidity. OC tissue engineering
emerged as a promising alternative strategy for OCD regeneration
[8–11]. It has been reported that the cartilage cannot spontane-
ously repair without support from healthy subchondral bone
[12]. Therefore, the rehabilitation of the subchondral bone should
be performed simultaneously with the reconstruction of the carti-
lage layer.
The development of bioactive bilayered scaffolds for OCD regen-
eration has been considered a desirable strategy [13–16]. Growth
factors have been introduced into the bilayered scaffolds to
enhance cartilage repair [15,16]. Spatially controlled dual-growth
factors or gene-release systems have also been developed and both
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[17,18]. On the other hand, the incorporation of osteoconductive
materials into bilayered scaffolds was able to promote the fast sub-
chondral bone formation [19,20]. Some commercial bilayered
scaffolds, e.g. Truﬁt and MaioRegen, have been applied clinically
in acellular strategies [21–23]. Kon et al. [21] showed that multi-
layer collagen/nanohydroxyapatite scaffolds promoted bone and
cartilage tissue restoration. Nevertheless, improvement in the
mechanical properties/stability of bilayered scaffold and optimiza-
tion of the incorporation of bioactive factors in the scaffolds are still
big challenges [17,24,25]. Other problems are related to achieving a
good interface between the different layers [26].
Natural biopolymers have been used for tissue regeneration and
presented superior in vitro and in vivo compatibility [27,28].
Among natural polymers, silk ﬁbroin (SF) exhibits tunable mechan-
ical properties [29], and thus has been ﬁnding a range of
applications in tissue engineering [30–34]. Calcium phosphate
(CaP)-based materials have been found to show outstanding
osteoconductivity in bone regeneration [35,36]. Development of
polymer/CaP composite scaffolds is a promising strategy to over-
come the low elasticity of CaP [20,21]. Previously, robust SF and
silk/nano-sized CaP (silk-nanoCaP) scaffolds have been produced
[37,38]. These scaffolds were able to promote in vivo new bone for-
mation [39]. Based on these promising outcomes, our group
recently developed a novel bilayered scaffold composed of a silk
layer and a silk-nanoCaP layer for OCD regeneration and character-
ized some preliminary properties of the scaffolds [40].
In this study, we aim to comprehensively understand the phys-
icochemical properties of the bilayered scaffolds and evaluate their
biological performance for OCD regeneration. The composition and
structure of the scaffold were evaluated by Fourier transform infra-
red spectroscopy (FTIR), micro-computed tomography (micro-CT)
and energy-dispersive X-ray spectrometry. Both dynamic and sta-
tic mechanical properties were analyzed. Cytocompatibility was
evaluated by studying the viability and proliferation of rabbit bone
marrow mesenchymal stromal cells (RBMSCs) in the scaffolds.
Osteogenic differentiation of the RBMSCs in the scaffold was also
examined. The bilayered scaffolds were implanted both subcutane-
ously and in critical size OCDs of the rabbit knee. The regeneration
of osteochondral tissues in these explants were characterized by
micro-CT, and by histological and immunohistochemical staining,
respectively.2. Materials and methods
2.1. Materials and reagents
Bombyx mori cocoons were supplied by the Portuguese
Association of Parents and Friends of Mentally Disabled Citizens
(APPACDM, Castelo Branco, Portugal). The other materials and
reagents were purchased from Sigma–Aldrich (St Louis, MO, USA)
unless mentioned otherwise.2.2. Preparation of the bilayered scaffolds
The concentrated aqueous SF solution was obtained via a previ-
ously reported procedure [37]. Regarding the preparation of the
bilayered scaffolds, silk-nanoCaP scaffolds were ﬁrst prepared
[38]. Brieﬂy, calcium chloride solution (6 mol l1) and ammonia
dibasic phosphate solution (3.6 mol l1) of the same volume were
sequentially added to the 16 wt.% SF solution, forming the nano-
CaP particles in the silk solution. The amount of CaP introduced
was ﬁxed at 16 wt.% (CaP/silk, w/w). The scaffolds were prepared
by addition of sodium chloride particles into the suspension in a
silicon mold. The mold was dried for 2 days, and then immersedin distilled water overnight. During the following day, the silk-
nanoCaP scaffolds were cut into pieces after removal from the
molds. Each piece of scaffold was placed in the bottom of a new sil-
icon mold and 300 ll of 16 wt.% silk solution was added on top of
these scaffolds. Then, 600 mg of sodium chloride particles were
added to the silk solution [38]. After drying and salt-leaching pro-
cesses, the ﬁnal scaffolds were obtained by lyophilization in a
freeze drier (CRYODOS-80; Telstar, Barcelona, Spain). As controls,
pure silk scaffolds and silk-nanoCaP scaffolds were also prepared.
The pure silk scaffolds, the silk-nanoCaP scaffolds and the
bilayered scaffolds are abbreviated as S16, SC16 and bilayered,
respectively.
2.3. Physicochemical characterization of the bilayered scaffolds
2.3.1. Chemical analysis of the bilayered scaffolds
The chemical composition and structural conformation of the
bilayered scaffolds were analyzed by a Fourier transform infrared
spectroscopy (FTIR) under an attenuated total reﬂectance (ATR)
model (IRPrestige-21, Shimadzu, Kyoto, Japan) [39]. At least three
specimens were used for each layer.
The CaP content in the silk-nanoCaP layer was evaluated by
thermogravimetric analysis (TGA) [38]. The organic phase was
degraded by heating the specimen in the TGA instrument (TGA
Q500; TA Instruments, DE, USA). The Ca/P atomic ratio of the ash
obtained after the TGA assay was studied by an energy-dispersive
X-ray detector (EDX). At least three specimens were used for both
assays.
2.3.2. Microstructure evaluation of the bilayered scaffolds
The morphology of the scaffold was observed by scanning elec-
tron microscopy (SEM) (Nova NanoSEM 200; FEI, Hillsboro, OR,
USA). Before the observation, the scaffolds were coated with one
layer of Au/Pd (SC502–314B) in a coater (E6700; Quorum
Technologies, East Grinstead, UK). Elemental analysis was per-
formed in four zones around the interface area by an EDX setup
installed in the SEM. Three independent areas were selected in
each zone, and each scanned area was 100 lm 100 lm.
Micro-CT was used to qualitatively and quantitatively evaluate
the porosity and the CaP distribution proﬁle in the bilayered scaf-
folds. The scanning of the scaffolds was conducted under 61 keV
and 163 lA in the micro-CT (1072 scanner; SkyScan, Kontich,
Belgium). Both the diameter and the height of the scaffolds were
8 mm (silk layer: 3 mm in height; silk-nanoCaP layer: 5 mm in
height). The integration time was ﬁxed at 1.3 s and the pixel reso-
lution was 9.4 lm. Qualitative visualization of the 3-D morphology
and the different phases in the bilayered scaffolds were performed
using CTvox software (Skyscan). The porosity and CaP content dis-
tribution proﬁles were processed in standardized software (CT
Analyser, version 1.5., Skyscan) [38]. Five scaffolds were used for
the qualitative and quantitative microstructure evaluation.
2.3.3. Mechanical tests of the scaffolds
The wet status compressive test of the bilayered scaffolds was
performed in a universal testing machine (Instron 4505; Instron,
Norwood, MA, USA). The diameter and the height of the scaffolds
were 6 and 5 mm, respectively (silk layer: 2 mm in height; silk-
nanoCaP layer: 3 mm in height). Before the test, the samples were
ﬁrst hydrated in phosphate buffer saline solution (PBS) overnight
at 37 C. After removing the liquid with a tissue, the samples were
tested using a previously reported protocol [39]. S16 and SC16
were used as controls (5 mm in height, 6 mm in diameter). For
each test, six specimens of each group were screened.
Dynamic mechanical analysis (DMA) was also conducted to
study the viscoelastic properties of the bilayered scaffolds. The
sizes of the scaffolds were the same as for the compressive test.
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DMA; Triton Technology, Lincolnshire, UK) [38]. Five samples of
each group were tested.2.4. In vitro degradation
The stability of the bilayered scaffolds was evaluated by enzy-
matic degradation test. Protease XIV solution (1 mg l1) was pre-
pared by dissolving the enzyme in PBS. The initial dry weight of
the scaffold was measured, and then the scaffolds were hydrated
in PBS at 37 C for 3 h, followed by immersion in 5 ml of protease
solution. The scaffolds were the same size as those used for the
compressive test. The enzyme solution was changed every 24 h.
The specimens were removed from the degradation solution at
the end of 0.5, 1, 2, 3, 5 and 7 days. The dry weight of the degraded
specimen was measured after drying the sample at 70 C over-
night. The weight loss ratio was obtained using the following
equation:
weight loss ratio ¼ ðmi md;tÞðmiÞ
 
 100% ð1Þ
where mi is the initial dry weight of the sample, and md,t is the dry
weight of the degraded sample at each time point. S16 and SC16
were used as controls. Five specimens per group were used for each
time point.2.5. In vitro cell studies
2.5.1. Isolation, expansion and seeding of the RBMSCs
The RBMSCs were isolated from male New Zealand White rab-
bits (Charles River, Senneville, Quebec, Canada). The maintenance
and usage of animals were approved by the Ethics Committee of
the University of Minho. The 9 week old rabbits were killed by
injecting an overdose of anesthetic. The femurs were ﬁrst separated
from the hind legs, followed by removing the epiphyseal heads and
subsequently ﬂushing out the bone marrow plug by using alpha-
minimum essential medium (a-MEM) (Gibco; Life Technologies,
Carlsbad, CA, USA). The a-MEM was supplemented with 10% fetal
bovine serum, and 1% antibiotic–antimycotic liquid prepared with
10,000 units ml1 penicillin G sodium, 10,000 lg ml1 streptomy-
cin sulfate and 25 lg ml1 amphotericin B as Fungizone in 0.85%
saline (Life Technologies, Carlsbad, CA, USA). The isolated RBMSCs
were cultured in cell culture ﬂasks at 37 C in an incubator with
5% CO2 atmosphere (MCO-18AIC (UV), Sanyo, Osaka, Japan). The
mediumwas changed for the ﬁrst time after 4 days, and then chan-
ged every 2 days until the cells reached 90% conﬂuence. The cells
were then expanded until passage 2 before seeding in the scaffolds.
All the scaffolds were sterilized with ethylene oxide (ETO).
For the cell seeding, bilayered scaffolds 6 mm in diameter and
5 mm in height were used (silk layer: 2 mm in height; silk-nano-
CaP layer: 3 mm in height). S16 and SC16 (6 mm in diameter and
2 mm in height) were seeded with cells and used as controls for
osteogenic differentiation. Before the cell seeding, the scaffolds
were hydrated in a-MEM overnight in the CO2 incubator.
Afterwards, the scaffolds were removed from the medium and
placed into a 24-well suspension cell culture plate (Cell star;
Greiner Bio-One, Kremsmuenster, Austria). RBMSCs of passage 2
were detached from the ﬂasks and a new cell suspension with a
cell density of 5  106 ml1 was prepared (P3). The cells were
seeded onto the surface of the scaffolds, and then the scaffolds
with cells were kept in the CO2 incubator. After 3 h, the constructs
were transferred to a new 24-well suspension culture plate and
each construct was supplemented with 2 ml of a-MEM. The cul-
ture medium was refreshed every 2 or 3 days.2.5.2. Viability, attachment, proliferation and differentiation of the
RBMSCs
For the cell viability assay, 100,000 cells were seeded onto the
bilayered scaffolds and cultured in basal condition. The live/dead
numbers of seeded cells were analyzed by Calcein AM and propidi-
um iodide (Molecular Probes; Life Technologies, Carlsbad, CA,
USA) staining after culturing for 3 days. First, each construct was
washed with PBS, and then transferred into 1 ml PBS supple-
mented with 1 lg calcein AM and 2 lg propidium iodide, for
10 min. The samples were observed in a transmitted and reﬂected
light microscope with apotome 2 (Axio Imager Z1 m; Zeiss, Jena,
Germany) after rinsing twice wirh PBS. By using the accompanying
software Zen, a Z-stack function was used to combine images at
different depths into one ﬁnal image.
The quantitative cell viability of the constructs was screened by
a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) assay (MTS) using the CellTiter 96
AQueous One Solution Cell Proliferation Assay Kit (Promega,
Fitchburg, WI, USA), after culture for 1, 3 and 7 days. The MTS assay
followed the manufacturer’s instruction. After 3 h of reaction with
cells, 100 ll MTS solution was transferred into a 96-well cell
culture plate and read in a microplate reader (Synergy HT;
Bio-Tek, VT, USA) at 490 nm. The scaffolds without cells were used
as control.
The cells’ attachment on the scaffolds in basal condition was
observed by SEM, after culturing for 7 days. Before the observation,
the constructs were harvested from the medium and rinsed by PBS,
followed by immersion in 10% formalin solution for at least 1 day.
The ﬁxed constructs were dehydrated by immersion in a series of
aqueous ethanol solutions, with a gradually increasing concentra-
tion of ethanol (from 30% to 100%). The surface of the constructs
were coated by Au/Pd and observed by SEM.
For the cell proliferation and osteogenic differentiation assay,
200,000 cells were seeded onto the bilayered scaffolds. The follow-
ing day, the constructs were cultured in basal medium (a-MEM) or
osteogenesis medium, respectively. The osteogenic medium was
based on the a-MEM, and supplemented with 10 mmol l1 b-glyc-
erophosphate, 50 lg ml1 ascorbic acid (Wako Pure Chemicals,
Tokyo, Japan) and 108 mol l1 dexamethasone. The constructs
were harvested after culturing for 7 and 14 days. At the end of each
time point, the silk layer and the silk-nanoCaP layer were sepa-
rated by a blade, and each part was placed into 1 ml ultrapure
water in a 1.5 ml centrifuge tube after rinsing in PBS. The silk layers
cultured in basal or osteogenic conditions were abbreviated as
Cart.Basal or Cart.Osteo, respectively. The silk-nanoCaP layer cul-
tured in basal or osteogenic conditions were abbreviated as Bone.-
Basal or Bone.Osteo, respectively. S16 and SC16 were seeded with
100,000 cells per scaffold. The quantiﬁcation of the double-
stranded DNA (dsDNA) was performed by using a Quant-IT
PicoGreen dsDNA Assay Kit 2000 assay (Life Technologies,
Carlsbad, CA, USA) according to the manufacturer’s instructions.
The ﬂuorescence intensities of the samples were recorded in a
microplate reader [14]. The same lysates for DNA assay were also
used for alkaline phosphatase (ALP) activity quantiﬁcation [14].
The ALP activity of the samples was normalized by their corre-
sponding DNA contents. The DNA contents or ALP activities of
the bilayered scaffolds were obtained by combining the DNA
contents or ALP activities of the corresponding silk layer and silk-
nanoCaP layer.
2.6. In vivo implantation of the bilayered scaffolds
In order to evaluate the in vivo biocompatibility and OCD regen-
eration potential of the bilayered scaffolds, the scaffolds were sub-
cutaneously implanted in the back and the knee OCD of male New
Zealand White rabbits, respectively. The bilayered scaffolds 6 mm
Fig. 1. ATR-FTIR spectra of (a) the silk layer and (b) the silk-nanoCaP layer in the
bilayered scaffolds. The inserted image is a backscattered SEM image of the silk-
nanoCaP layer, showing the nanosized CaP particle (white domain) distribution in
the silk matrix (scale bar: 3 lm).
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5 mm) were used for the subcutaneous implantation. Additionally,
the bilayered scaffolds 5 mm in diameter and 5 mm in height (silk
layer: 2 mm; silk-nanoCaP: 3 mm) were implanted in the OCD. All
the rabbits for the in vivo studies were of 9–11 weeks old, with an
average weight of 2.4 kg at the time of implantation. The scaffolds
were sterilized with ETO.
For the subcutaneous implantation, six bilayered scaffolds were
implanted into three rabbits (2 pieces/rabbit). In each rabbit, two
skin incisions were made below the ears in the back (one on the
left and the other on the right), each 2 cm length. The scaffolds
were subcutaneously implanted into each pocket. After 4 weeks,
the rabbits were killed by injecting an overdose of anesthetic and
the implanted scaffolds were retrieved. The explants were ﬁxed
in 10% formalin, and then dehydrated through graded ethanol,
and ﬁnally embedded in parafﬁn. Sections were prepared by cut-
ting the specimen into sections 5 lm thick using a microtome
(Spencer 820, American Optical Company, NY, USA). The obtained
sections were stained with hematoxylin and eosin (H&E). The
dehydrated explants were also coated with Au/Pd and observed
by SEM.
Regarding the implantation in critical size OCDs (4.5 mm in
diameter and 5 mm in depth), nine bilayered scaffolds were
implanted into three rabbits (3 pieces/rabbit). The rabbits were
anesthetized and the hair in the knee joints of the hind legs was
cut. Two OCDs (4.5 mm in diameter and 5 mm in depth) were cre-
ated in each femur using a Brace manual drill, one located between
the lateral and the medial condyle, the other in the opposite site of
the patellar. The bilayered scaffolds were implanted into the
defects by press ﬁtting. In each rabbit, one defect located between
the lateral and the medial condyle was empty and was used as con-
trol. Four weeks post-operation, the rabbits were killed and the
knees were excised. Three explants were ﬁxed by 10% formalin
and then immersed in parafﬁn after dehydration. Slides were pre-
pared and H&E, Masson’s trichrome and Safranin O stainings were
performed.
2.7. Immunohistochemical staining of the explants
Mouse anti-rabbit collagen II alpha 1 (Acris Antibodies GmbH,
Herford, Germany) and biotinylated Sambucus nigra (Elderberry)
bark lectin (SNA-lectin; Vector Laboratories, Burlingame, CA,
USA) were used for the immunohistochemical staining of the
explants following the protocol provided by the supplier. After
deparafﬁnization and rehydration of the specimen slides, the anti-
gens were retrieved in 0.01 mol l1 sodium citrate buffer solution
at 95 C for 20 min (pH 6.0), and then the endogenous peroxidases
were inactivated by using 3% (v/v) hydrogen peroxide solution. For
collagen II immunohistochemical staining, the specimen slides
were subsequently incubated overnight at 4 C after addition of
the primary antibodies. Then, the slides were incubated with sec-
ondary antibody donkey anti-mouse Alexa Fluor 594 (Molecular
Probes, Eugene, OR, USA). The nuclei of the cells in the slides were
counterstained with 40,6-diamidino-2-phynylindole (DAPI) solu-
tion (1 lg ml1 in PBS) for 10 min. Finally, the slides were mounted
and observed in a ﬂuorescence microscope. The SNA-lectin immu-
nohistochemical analysis was performed according to the strepta-
vidin–biotin peroxidase complex system (UltraVision Large
Volume Detection System Anti-Polyvalent, HRP; LabVision
Corporation, Fremont, CA, USA). After inactivation of the endoge-
nous peroxidases and soaking in PBS, the slides were incubated
in protein blocking solution for 10 min followed by incubation
with the primary antibody SNA-lectin for 1 h and at room temper-
ature. Sections were then sequentially washed with PBS and
incubated with the streptavidin–peroxidase complex for 10 min.
The immune reaction was visualized by 3,30-diamonobenzidine(DAB; LabVision Corporation, Fremont, CA, USA) as a chromogen.
All sections were counterstained with Gill-2 hematoxylin (Merck,
Germany). For preparing the negative controls, the primary anti-
body was omitted. The histological sections were then observed
using a light microscope.
2.8. Micro-CT analysis of the explants
Three explants were used for micro-CT observation in the wet
state, under 100 keV and 98 lA. The explants were loaded with
Paraﬁlm during the scanning to avoid evaporation of liquid. The
integration time was ﬁxed at 1.3 s and the pixel resolution was
19.13 lm. The specimens were ﬁrst scanned and the data sets were
processed as mentioned above (Section 2.3.2). In each specimen, a
cylindrical model region (height: 4 mm; diameter: 4 mm) was
used for the evaluation of porosity and CaP distribution. The top
2 mm region in the cylindrical model region was considered as car-
tilage domain in defect controls or as silk layer in defects
implanted with scaffolds, and the next 2 mm region down was
considered as subchondral bone domain in defect controls or as
silk-nanoCaP layer in defects implanted with scaffolds.
2.9. Statistical analysis
The data were presented by mean ± standard deviation (SD).
The results were evaluated by one-way analysis of variance
(ANOVA). The means of each group were compared by Tukey’s test,
and P < 0.05 was considered statistically signiﬁcant. Three inde-
pendent experiments were performed for the cell viability assay,
the proliferation and differentiation studies, and at least three
samples were analyzed for each time point in every experiment.
3. Results
3.1. Chemical composition and structural conformation of the
bilayered scaffolds
The SF conformation and chemical composition in the bilayered
scaffolds were studied by ATR-FTIR. As shown in Fig. 1, the SF in
both layers displayed the same strong absorbance peaks at 1627
and 1520 cm1, which are characteristic peaks for b-sheet confor-
mation [30]. It was noticed that both layers presented shoulder
peaks 1650 cm1 corresponding to amorphous or silk-I
Table 1
Microstructure and CaP content of the bilayered scaffolds analyzed by micro-CT.
Mean
porosity (%)
Mean
interconnectivity (%)
Mean CaP
content
(vol.%)
Silk layer 82.02 ± 1.15 91.13 ± 2.32 0
Silk-nanoCaP layer 62.27 ± 2.61 70.03 ± 4.62 9.60 ± 0.81
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at 1031 cm1, which is the characteristic vibration absorbance of
PO43 in the CaP [42]. The size of the nano-CaP particles was ana-
lyzed by back-scattered SEM. The inserted SEM image shows that
the CaP particles were distributed evenly in the silk matrix, and
were 200 nm in size. TGA showed that the CaP mass ratio in
the silk-nanoCaP layer was 13.81 ± 0.63% (CaP/Silk, w/w), and
the Ca/P ratio of the ash was 1.65 ± 0.4%.
3.2. Microstructure and CaP distribution of the bilayered scaffolds
Fig. 2 shows a macroscopic image of the bilayered scaffolds. It
was found that the scaffold presented macro/microporous and
interconnective structure in both layers. The two layers were well
integrated by a continuous interface region. The pore size of the
macropores in each layer was 300–700 lm, and the micropores
were located in the trabeculae of the macropores with size
<50 lm (Fig. 2b). The interface region was < 500 lm thick and
located ﬂat between the two layers (Fig. 2b). EDX scanning from
the silk-nanoCaP layer to the silk layer showed that calcium ions
were only limited in the silk-nanoCaP layer and the thin interface
area (Fig. 2c). In the interface region, the intensity of the calcium
ion signal on the side close to the silk-nanoCaP layer was higher
than the one in the side of the silk layer.
The qualitative and quantitative distributions of the porosity
and the CaP in the bilayered scaffolds were assessed by micro-
CT. Table 1 demonstrates that both layers presented high porosity
and interconnectivity, and the CaP was retained only in theFig. 2. The interface of the bilayered scaffolds. (a) Macroscopic image of the
bilayered scaffolds (scale bar: 3 mm). (b) SEM image of the interface region in the
bilayered scaffold (scale bar: 500 lm). Z1, Z2, Z3 and Z4 indicate different regions
from the silk layer to the silk-nanoCaP layer, around the interface area. (c) EDX
elemental analysis of calcium ions in Z1, Z2, Z3 and Z4 regions.silk-nanoCaP layer. The 3-D images showed two distinct phases
in the bilayered scaffold (Fig. 3a). The CaP (blue domain) resided
only in the silk-nanoCaP layer, without inﬁltration into the silk
layer. Both layers displayed high interconnectivity and porosities
(Fig. 3a). By changing the threshold, it was found that the CaP dis-
tribution was homogeneous in the silk-nanoCaP layer (Fig. 3b). The
2-D images of each layer also conﬁrmed the interconnectivity and
porous structure in each layer (Fig. 3c and d). The porosity distribu-
tion proﬁle revealed that the porosity was homogeneously
distributed in each layer, and lower porosity was observed in the
silk-nanoCaP layer (Fig. 3e). The porosity showed a sharp decrease
in the interface domain which was 0.5 mm in thickness. The CaP
was distributed evenly in the silk-nanoCaP layer (Fig. 3f). It was
noticed that the CaP content decreased gradually in the thin inter-
face region and there was no CaP in the silk layer (Fig. 3f).3.3. Mechanical and degradation properties of the bilayered scaffolds
As shown in Fig. 4a, the wet state modulus of the bilayered scaf-
folds was 0.4 MPa, similar to the ones of the controls. The
dynamic viscoelastic properties of the scaffolds were evaluated
by DMA. It was found that the storage modulus of the bilayered
scaffolds increased from around 0.5 to 0.8 MPa as the frequency
increased from 0.1 to 20 Hz (Fig. 4c). In the frequency range tested,
the storage modulus values of the bilayered scaffolds were similar
to those of SC16 and higher than those of S16. All the three group
scaffolds demonstrated similar and low loss factor values for the
tested frequencies. The loss factor (tan d) of the bilayered scaffolds
increased slightly from around 0.17 to 0.23 when the frequency
increased from 0.1 to 20 Hz. In this study, the enzymatic degrada-
tion proﬁles of the scaffolds were analyzed by using protease XIV.
It was found that S16 degraded faster than the bilayered scaffolds
and SC16 (Fig. 4b). In the ﬁrst 12 h, the bilayered scaffolds lost
12% mass, and S16 and SC16 lost 14% and 7% mass, respec-
tively. After 7 days of degradation, the bilayered scaffolds pre-
sented 27% weight loss, and S16 and SC16 showed 43% and
22% weight loss, respectively.3.4. Attachment, viability and proliferation of the RBMSCs on the
bilayered scaffolds
The RBMSCs were seeded into the bilayered scaffolds. The live/
dead assay showed that there were living cells attached on the sur-
face of the scaffolds (Fig. 5a–c), after seeding for 3 days. The cells
dispersed evenly in the silk and silk-nanoCaP layers, presented a
spreading morphology, and contacted with each other. Some cells
also grow on the interface area. Cell attachment was also observed
by SEM after culturing for 7 days in basal condition (Fig. 5d–f). It
was found that the surface of the silk layer, the silk-nanoCaP layer,
and the interface were fully covered by the cells and the extracel-
lular matrix, in both basal and osteogenic conditions. The cells not
only adhered to the surface of the scaffolds, they also grew inside
the scaffolds to a depth of at least 1 mm (Fig. 5g, h).
Quantitative analysis of the cell viability was performed by MTS
assay (Fig. 6a). It was observed that the MTS absorbance signiﬁ-
cantly increased during the culture period. Cell proliferation was
Fig. 3. Micro-CT analysis of the bilayered scaffolds. (a) 3-D image of the silk matrix (brown) and the CaP distribution (blue), and (b) 3-D image of the pure CaP distribution in
the bilayered scaffold (scale bar: 4 mm). (c) 2-D image of the silk layer, and (d) 2-D image of the silk-nanoCaP layer (scale bar: 1 mm). (e) Quantitative analysis of the porosity
distribution, and (f) quantitative analysis of the CaP distribution in the bilayered scaffolds.
Fig. 4. Mechanical analysis and degradation proﬁle of the bilayered scaffolds. (a) Wet status compressive modulus and (b) enzymatic degradation proﬁle of the bilayered
scaffolds and the controls. (c) Storage modulus (E0) and (d) loss moduli (tan d) of the bilayered scaffolds and the controls obtained by DMA, tested at 37 C in PBS.
232 L.-P. Yan et al. / Acta Biomaterialia 12 (2015) 227–241screened by DNA content analysis. It was seen that the DNA con-
tent of the bilayered scaffolds signiﬁcantly increased from day 7
to day 14, in both the basal and osteogenic conditions (Fig. 6b).
At day 14, the DNA content of the bilayered scaffold in the basal
condition was higher than that in osteogenic media (Fig. 6b).3.5. Osteogenic differentiation of RBMSCs in the bilayered scaffolds
The ALP activity from the cells seeded in the bilayered scaffolds
and the controls were normalized by their respective DNA content
(Fig. 6c). It was found the ALP activity in all the groups increased
Fig. 5. The live/dead staining and attachment of RBMSCs in the bilayered scaffolds. (a–c) Calcein AM and propidium iodide staining of the bilayered scaffolds, after culturing
RBMSCs in the scaffolds in basal condition for 3 days (scale bar: 400 lm). (d–f) SEM images of the cell attachment on the surface of the bilayered scaffold. (g, h) Longitudinal
section SEM images of the bilayered scaffolds showing the cell migration into the inner domain after culturing for 7 days in basal condition: (g) silk layer and (h) silk-nanoCaP
layer (scale bar: 500 lm).
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the ALP activity showed no differences during the culture time. In
osteogenic conditions, the ALP activity of the silk-nanoCaP layer
was signiﬁcantly higher than that of the silk layer at both tested
time points. The same trend was observed in the controls. The
ALP activity of SC16 was higher than that of S16 in day 7 and
day 14, when cultured in osteogenic conditions.
3.6. Subcutaneous implantation of the bilayered scaffolds
The in vivo compatibility of the bilayered scaffolds was assessed
by subcutaneous implantation in rabbit. Fig. 7a showed that the
bilayered scaffolds were still integrated after 4 weeks of implanta-
tion. A layer of connective tissue adhered on the entire surface of
the scaffolds, and no signs of infection or acute inﬂammation were
observed. The SEM images of the explants showed that the connec-
tive tissues not only tightly integrated to the implants, but also
fully ﬁlled the inner pores of the bilayered scaffolds (Fig. 7b). The
H&E staining image of the bilayered scaffolds showed that the con-
nective tissues inﬁltrated into the pores of the scaffolds (Fig. 7c–e).
There were some vessels formed inside the scaffolds (Fig. 7c). Only
a fewmacrophages were observed in the inner part of the scaffolds.
There were also some ﬁbroblasts presented in the silk-nanoCaP
layer.
3.7. Regeneration of rabbit knee OCDs by the bilayered scaffolds
The OC regeneration potential of the bilayered scaffolds was
studied by implantation of these scaffolds in rabbit OCDs for
4 weeks. The macroscopic images of the explants demonstrated
that the scaffolds were integrated well with the host tissue
(Fig. 8a). The scaffolds implanted displayed no obvious mass loss.There were no apparent signals of infection of the implants. The
defect controls were not regenerated and formed a large void with
apparent adjacent tissue collapse. The micro-CT analysis of the
explants illustrated that the defect ﬁlled with the bilayered scaf-
fold presented less void space and more regular morphology com-
pared with the defect control (Fig. 8b). Moreover, both the
ingrowths of the subchondral bone in the bottom domain and
the regeneration of cartilage in the surface area of the implant
were observed. From the micro-CT data, it is not easy to clearly
determine the amount of CaP coming from the scaffold and the
new bone. However, based on the scanning parameter (high volt-
age) chosen for this assay, the detected CaP may mainly come from
the newly formed subchondral bone. The defect control showed no
cartilage regeneration and little subchondral bone formation. The
porosity distribution showed that the defect control was empty
in the top region and ﬁlled by the tissues in the bottom region,
while the defects with implants showed <20% porosity in the
region analyzed (Fig. 8c). The defect control showed only a very
small amount of subchondral bone regeneration in the bottom,
but the defect with the implant presented a large amount of CaP
content in the silk-nanoCaP layer (Fig. 8d). The quantitative results
of CaP content and porosity of different regions were presented in
Supplementary Table 1. The defect controls showed much higher
void space than the defects with implants. It was observed that
the CaP content in the silk-nanoCaP layer was 20% higher than
the one from the silk layer.
The explants were further evaluated by H&E and Masson’s tri-
chrome staining (Fig. 9). No acute inﬂammation was observed in
any of the explants. The defects with scaffolds showed no collapse
of adjacent tissues. The scaffolds presented a stable and integrated
structure, and were ﬁrmly integrated with the host tissues. In the
silk layer, the new cartilage formed and gradually spread from
Fig. 6. (a) The MTS analysis, (b) DNA content and (c) osteogenetic differentiation of the RBMSCs cultured in the bilayered scaffolds. Basal: Basal condition; Osteo: Osteogenic
condition. ⁄Indicates signiﬁcant differences between the different time points. & indicates signiﬁcant differences compared with DNA content from the osteogenic condition.
# and % indicate signiﬁcant differences compared with ALP activity from S16 group in the osteogenic condition at the 7th and 14th days, respectively. @ and § indicate
signiﬁcant differences compared with values from the silk layer in the osteogenic condition at the 7th and 14th days, respectively.
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the scaffolds showed no collapse, and matched the height of the
normal cartilage. In the bottom domain, obvious new subchondral
bone growth into the silk-nanoCaP layer was observed (Fig. 9a,b).
The inﬁltration of the subchondral bone was limited to the silk-
nanoCaP layer. From the cross-sectional staining, a low level of
deformation was observed. In addition, de novo bone inﬁltration
was observed in the subchondral part, which shows a good integra-
tion of the scaffolds in the host tissue (Fig. 9c,d). The defect control
showed no regeneration of the cartilage layer and the subchondral
bone (Fig. 9e,f). From the high-magniﬁcation Masson’s trichrome
staining images (Fig. 10a), it could be seen that the chondrocytes
in the neocartilage presented a normal round phenotype and grew
inside the silk layer. The defect control only showed loose tissue
formation (Fig. 10c). In the silk-nanoCaP layer, besides the obvious
new bone ingrowth, the formation of new vessels was also
detected (Fig. 10b). Some collagen ﬁber formed under the loose tis-
sue in the subchondral bone domain of the defect control
(Fig. 10d).
The formation of glycosaminoglycan (GAG) in the defect was
studied by Safranin O staining. It was found that the explants exhi-
bit GAG tissue-containing chondrocytes that formed in the edge
and extended into the interior region of the top silk layer
(Fig. 11a,b). However, the defect control did not present any posi-
tive staining of cartilage matrix (Fig. 11c,d). With the collagen II
immunohistochemical staining, it was found that the neocartilage
tissue formed inside the silk layer was positively stained for colla-
gen II (Fig. 12a). The defect control did not show positive staining
of collagen II (Fig. 12c). Considering the important role of angio-
genesis in bone regeneration, an immunohistochemical stainingof an angiogenic marker (i.e. SNA-lectin) was performed (Fig. 13).
The speciﬁcity of SNA-lectin for endothelial cells enabled observa-
tion of a substantial invasion of the silk-nanoCaP layer by the
endothelial cells (Fig. 13a). In the defect control (Fig. 13c), it was
possible to observe the endothelial cells mainly located in the sur-
face area of the defect. The enlarged SNA-lectin staining image
showed that abundant endothelial cells colonized the interior
region of the silk-nanoCaP layer, and the formation of new bone
and blood vessel was also identiﬁed (Fig. 13e). The defect control
did not present new bone formation and displayed much lower
endothelial cell density compared with the defect with implant
(Fig. 13g). The newly formed vessels in the defect control were
not as evident as those in the defect with implants (Fig. 13e,g).4. Discussion
OC tissue encompasses interconnected chondral and subchon-
dral bone layers, which present distinct properties. Only chondro-
cytes reside in the avascular chondral layer, with type II collagen
and proteoglycan being the main components in the extracellular
matrix. On the other hand, many kinds of cells (e.g. osteoblasts,
osteoclasts and bone marrow cells) exist in the vascularized sub-
chondral bone layer which primarily consists of hydroxyapatite
and type I collagen. Therefore, in OC tissue engineering, it is feasi-
ble to generate bilayered scaffolds that possess different features
(e.g. mechanical, chemical or morphology properties) in each layer
to satisfy the simultaneous regeneration of the chondral layer and
the subchondral bone layer. The ideal scaffolds for OCD regenera-
tion should be those that can promote cartilage regeneration on
Fig. 7. Subcutaneous implantation of the bilayered scaffolds in rabbit for 4 weeks. (a) Macroscopic image of the explants after implantation for 4 weeks (scale bar: 1 cm). (b)
SEM image of the explants after implantation for 4 weeks (scale bar: 1 mm), the arrow indicates the interface. (c–e) H&E staining of the silk layer, interface and silk-nanoCaP
layer in the explants after implantation for 4 weeks, respectively (scale bar: 200 lm). The arrow in (c) indicates vessels, and the arrow in (e) indicates ﬁbroblasts.
Fig. 8. Macroscopic image and micro-CT analysis of the explants after implantation in rabbit OCD for 4 weeks. (a) Macroscopic image of the explants; the black arrow
indicates the implanted scaffold, and the white arrow indicates the defect control (scale bar: 5 mm). (b) Micro-CT 3-D image of the explants; the grey arrow indicates
neocartilage, and the white arrow indicates new subchondral bone formation (scale bar: 4 mm). (c) Porosity and (d) CaP content distribution of the defect control and the
defect implanted with the bilayered scaffold.
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Fig. 9. The histological analysis of the explants from rabbit OCD. (a, b) H&E staining and Masson’s trichrome staining of the longitudinal section of the explants, respectively.
(c, d) H&E staining and Masson’s trichrome staining of the cross-section of the explants in the silk-nanoCaP layer, respectively. (e, f) H&E staining and Masson’s trichrome
staining of the longitudinal section of the defect, respectively. The black arrow indicates neocartilage formation in the silk layer of the bilayered scaffolds, and the white arrow
indicates new subchondral bone formation inside the silk-nanoCaP layer of the bilayered scaffolds. Scale bar: 1 mm.
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In this study, we proposed bilayered silk/silk-nanoCaP scaffolds for
OCD regeneration and evaluated their potential by in vitro and
in vivo studies. These bilayered scaffolds are based on our previous
works on high-strength SF scaffolds and nanocomposite silk/nano-
calcium phosphate scaffolds [37,38,43].
Compared to previous studies [37,38], the bilayered scaffolds
maintained the chemical properties (Fig. 1 and TGA) and the
microstructure (Figs. 2 and 3) of S16 and SC16 in the chondral
and subchondral layer, respectively. Tissue regeneration requires
that scaffolds present a porous and interconnected structure, as
well as a suitable pore size and distribution [44]. It has been
reported that a pore size larger than 300 lm is favorable for cell
proliferation, nutrients exchange and new tissue formation in bone
regeneration; and the micropores related to the surface roughness
are good for cell attachment. Thus, the macro/microporous struc-
ture in the subchondral layer may promote better cell attachment,
bone tissue ﬁltration and angiogenesis compared with the sole
macroporous or microporous structure.
Based on their adequate performance for bone regeneration
[35], it is believed that CaP-based materials also favor subchondral
bone regeneration. However, it was also reported that CaP caninduce the hypertrophy of chondrocytes [45]. It is important to
precisely control the distribution of the CaP in the bilayered scaf-
folds, avoiding the CaP migration to the layer free of CaP
(addressed to cartilage). EDX (Fig. 2b,c) and micro-CT (Fig. 3a,b,f)
analyses demonstrated that the introduced CaP was clearly con-
ﬁned to the silk-nanoCaP layer.
The mechanical property of the scaffolds is one of the main
issues when addressing bone and cartilage tissue regeneration
[51]. Improving the mechanical properties of the scaffolds is a
major challenge for skeletal-related tissue engineering. Some stud-
ies have been performed to produce silk-based scaffolds of high
strength for bone tissue engineering [52,53]. The typical Young’s
modulus of articular cartilage was reported to be 1 MPa [54].
Despite the different testing approach, the strength of the bilay-
ered scaffolds is comparable to that of human articular cartilage
(Fig. 4a). Table 2 listed the mechanical properties of previously
reported natural polymer scaffolds. It was reported previously
the bilayered scaffolds have a dry compressive modulus of
16 MPa [40]. In comparison with other previous studies on silk-
based scaffolds, the bilayered scaffolds described herein present
superior compressive modulus [30,47,48,50,46]. Furthermore, the
modulus of the bilayered scaffolds was much higher than those
Fig. 10. High-magniﬁcation Masson’s trichrome staining images of the explants. (a) Neocartilage formed in the top silk layer. (b) Cross-section of the explants in the silk-
nanoCaP layer. ‘‘NB’’ indicates the formed new bone inside the scaffold, ‘‘S’’ indicates scaffold and the arrow indicates new vessel formation. (cm d) Cartilage and subchondral
bone domains in the defect control, respectively. Scale bar: 200 lm.
Fig. 11. Safranin O staining images of the explants. (a, b) Glycosaminoglycan and proteoglycan tissues formed in the edge and the inner domain of the top silk layer,
respectively. Arrow indicates newly formed tissue, ‘‘S’’ indicates scaffold. (c, d) Tissue formation in the cartilage and subchondral bone domains of the defect control,
respectively. Scale bar: 200 lm.
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implanted in the body undergo dynamic loading, and thus it is cru-
cial to know their dynamic mechanical properties under physiolog-
ical conditions. It was demonstrated that the binding strength of
the two layers was excellent, as the bilayered scaffolds maintained
their integrity under high-frequency loading. The low loss factor
showed that these scaffolds were of low viscosity and high
elasticity.
In an ideal tissue engineering approach the scaffolds should
degrade in the body after implantation. In previous studies, itwas shown that salt-leaching scaffolds gradually lost weight when
immersed in isotonic solution for 1 year [39]. SC16 displayed a
slightly higher weight loss proﬁle as compared with S16, due to
the dissolution of CaP. When implanted, the scaffolds would con-
tact with the body ﬂuid, which is rich in enzymes. The study of
the enzymatic degradation of scaffolds is of great importance to
predict their in vivo stability. The bilayered scaffold, containing
both silk layer and silk-nanoCaP layer, presented a degradation
ratio in between those observed for S16 and SC16. The differences
in the degradation proﬁles could be attributed to the formation of
Fig. 12. Collagen II immunohistochemical staining of the explants. (a, c) Collagen II staining for the neocartilage formed in the silk layer and the defect control, respectively.
(b, d) Negative control for (a, c), respectively. (a, b) Arrows indicate collagen II (red) in the regenerated cartilage, blue domain indicates the scaffold. Scale bar: 100 lm.
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formed a nanosize complex which hindered the enzymatic degra-
dation process.
In order to achieve good tissue regeneration outcomes, it is nec-
essary to evaluate the cytotoxicity of the scaffolds by seeding cells
onto the scaffolds and observing cell viability, attachment, prolifer-
ation and differentiation. Bone marrow stromal cells are multipo-
tent somatic stem cells and can be differentiated into osteoblasts,
chondrocytes and adipocytes [16]. They have been studied as cell
sources for OCD regeneration [16]. The outstanding performance
of the bilayered scaffolds for cell seeding was related to the intrin-
sic properties of SF and CaP, as well as to the porous structure of
the scaffolds. SF ﬁber has long been used as a suture for wounds
[55] due to its compatibility with human tissues. SF-based bioma-
terials can be proteolytically degraded and subsequently metabo-
lized in vivo [55]. SF has been prepared into membranes and
scaffolds for cell culture or implantation, and the outcomes were
satisfactory [29]. CaP-based materials, presenting similar chemical
properties to the inorganic phase in bone, have thus been devel-
oped into implantation materials for bone regeneration [56]. The
salt-leaching/freeze-drying approach endowed the bilayered scaf-
folds with proper hydration property [40], suitable pore size, high
porosity and interconnectivity, all of which are important for sup-
porting cell ingrowth, migration, proliferation and nutrient
transportation.
Interestingly, the silk-nanoCaP layer induced a higher ALP activ-
ity as compared with the silk layer when the bilayered scaffolds
were cultured in osteogenic medium (Fig. 6c). ALP is an important
marker of osteogenesis differentiation. This indicates that the
incorporated CaP facilitated the RBMSCs toward osteogenic differ-
entiation. The observation from S16 and SC16 also conﬁrmed this
conclusion. This result also conﬁrmed that the silk layer was not
affect by the silk-nanoCaP layer during the osteogenic differentia-
tion of RBMSCs, and the silk-nanoCaP layer was suitable for sub-
chondral bone regeneration. This data can be related to the
previous observation that only the silk-nanoCaP layer supports
apatite crystal formation when the bilayered scaffolds are
immersed in simulated body ﬂuid [40]. Our observation is also in
line with the previous study on CaP/silk hybrid scaffolds [57]. Inthat study, the CaP/silk scaffolds induced higher ALP activity com-
pared with the silk scaffold.
The compatibility between the bilayered scaffolds and in vivo
tissues was ﬁrst analyzed by subcutaneous implantation. Due to
the crystalline structure of the SF, the bilayered scaffolds main-
tained their integrity and kept their shapes. This result also
revealed that the scaffolds retained good mechanical strength
in vivo, which is in good agreement with the in vitro wet compres-
sive modulus analysis. These scaffolds can support tissue ingrowth
and angiogenesis, present good biocompatibility in vivo, and only
induce minimum foreign body reaction (Fig. 7). The high porosity
and interconnected structure (Figs. 2 and 3) contribute to the tis-
sue ingrowth and angiogenesis of the bilayered scaffolds. Similarly,
a previous study on SF-ﬁber-reinforced SF scaffolds showed
inﬂammatory cells surrounded all the scaffolds at the ﬁrst week
and fewer inﬂammatory cells at the fourth week, in a subcutaneous
mice model [52].
To evaluate the potential of the bilayered scaffolds for OCD
regeneration, rabbit OCD was used as a model in this study.
Previously, it was reported that collagen/nanohydroxyapatite scaf-
folds (MaioRegen) would swell in contacted with blood, causing
problems with ﬁxation [21]. In this study, the ﬁxing of the scaffolds
was easy and the scaffolds maintained their dimensions without
obvious swelling when in contact with body ﬂuid during the
implantation, which is of clinical relevance. It is obvious that sig-
niﬁcant swelling of the scaffolds could cause problems during
implantation, such as scaffold protrusion into the meniscus
domain. Besides the good stability observed for the bilayered scaf-
folds, these scaffolds also promoted subchondral bone regenera-
tion (Fig. 8d and Supplementary Table 1). Based on the scanning
condition used for the explants during the micro-CT analysis, the
CaP content detected in the silk-nanoCaP layer mainly came from
the newly formed subchondral bone. In a clinical trial, it was
reported that the failure in the reconstruction of patellar came
from the slow regeneration of subchondral bone [22]. The promis-
ing results in this study showed that the implantation of the bilay-
ered scaffolds in a rabbit knee osteochondral critical size defect can
induce rapid subchondral bone integration and healing. The fast
formation of new subchondral bone is critical to ﬁx the implant
Fig. 13. SNA-lectin immunohistochemical staining of the explants. (a, c) SNA-lectin staining for the endothelial cells invading the silk-nanoCaP layer (indicated by arrows)
and the defect control, respectively. (b, d) Negative control for (a, c), respectively. (e, g) High-magniﬁcation SNA-lectin staining images of the silk-nanoCaP layer and the defect
control, respectively (arrow indicated vessels). (f, h) Negative control for (e, g), respectively. ‘‘S’’ indicates scaffold, and ‘‘NB’’ indicates new bone. Scale bars: (a-d) 500 lm; (e-
h) 100 lm.
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regeneration of cartilage layer. In the empty defect, only a small
amount of subchondral bone was formed (Fig. 8d).
The regeneration of OC tissue was further evaluated by histo-
logical studies and immunohistochemistry. One of the challenges
for OCD regeneration is the formation of normal hyaline cartilage,
the main components of which are collagen II and GAG [10]. The
current study showed that the top silk layer was advantageous in
supporting cartilage regeneration, as indicated by signiﬁcant colla-
gen II formation (Fig. 12a) and GAG production (Fig. 11a,b), as well
as assisting the inﬁltration of chondrocytes with normalmorphology (Figs. 10 and 11). Another issue adversely affecting
OCD healing is rapid subchondral bone formation and vasculariza-
tion within the bone [34]. It has been reported that angiogenesis is
an important process during the formation of pre-vascular net-
works, and endothelial cells play a unique role in angiogenesis
[34]. Encouragingly, angiogenesis was clearly observed in the
silk-nanoCaP layer (Fig. 13a,e). Furthermore, the silk-nanoCaP
layer could induce new bone ingrowth and vessel formation
(Figs. 10b and 13e); the latter would be helpful for new bone
formation. These results have shown that the silk/silk-nanoCaP
bilayered scaffolds support the rabbit knee OCD regeneration.
Table 2
Compressive modulus of 3-D porous natural polymer scaffolds.
Scaffold materials Compressive modulus (kPa), dry state Compressive modulus (kPa), wet state Porosity (%)
Silka 1,300 ± 40 75 92±1.3
Silkb 1,000 ± 75 <10 98 ± 1.0
Silkc 40 93
Chitosanc 35 80
Collagen Id 6.31 ± 0.33 75 ± 8
Hyaluronic acidd 1.33 ± 0.20 80 ± 01
Gelatine 801 ± 108 97.51
Gelatinf 80 ± 8 97
Silk/CaPg 16,700 ± 4,500 400 ± 102 Table 1
a Salt-leached SF scaffolds derived from 8% aqueous silk solution [30].
b Salt-leached SF scaffolds derived from 17% silk solution dissolved in hexaﬂuoroisopropanol [46,47].
c Freeze-dried scaffold derived from 2% aqueous solution [48].
d Freeze-dried scaffold derived 1% aqueous solution [49].
e Scaffold prepared by a combination of thermally induced phase separation and porogen leaching technique [50].
f Commercial gelatin scaffold: Gelfoam [50].
g Scaffolds prepared by a combination of salt-leaching/freeze-drying approach; the dry state modulus came from Ref. [40].
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This study proposed novel porous bilayered scaffolds, built up
by fully integrating a SF layer and a silk-nanoCaP layer, for OCD
regeneration. These scaffolds presented superior mechanical prop-
erties and suitable stability, as well as spatially controllable poros-
ity and CaP distribution and conﬁnement. The scaffolds supported
the attachment, viability and proliferation of RBMSCs in vitro.
Additionally, the silk-nanoCaP layer promoted better osteogenesis
differentiation of RBMSCs in osteogenic conditions as compared
with the silk layer. Furthermore, these scaffolds allowed tissue
ingrowth and induced only a very weak foreign body reaction
when subcutaneously implanted in rabbit. When implanted in rab-
bit knee critical OCDs, the bilayered scaffolds were integrated well
with the host tissues. Moreover, the bilayered scaffolds supported
cartilage regeneration in the top silk layer, and encouraged large
amounts of subchondral bone ingrowth and angiogenesis in the
bottom silk-nanoCaP layer. Although a long-term in vivo study is
necessary, the preliminary in vivo data of the bilayered scaffolds
together with their other desirable features conﬁrm that the silk/
silk-nanoCaP bilayered scaffolds are suitable for OCD regeneration.Conﬂict of interest
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Certain ﬁgures in this article, particularly Figs. 2, 3, 5, 7–13 are
difﬁcult to interpret in black and white. The full colour images can
be found in the on-line version, at http://dx.doi.org/10.1016/
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